Invesco
ALT icon

Invesco’s Altimmune ALT Stock Holding History

Invesco’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Buy
227,857
+13,033
+6% +$55.3K ﹤0.01% 3013
2025
Q4 		$776K Buy
214,824
+52,881
+33% +$231K ﹤0.01% 3022
2025
Q3 		$611K Buy
161,943
+55,080
+52% +$213K ﹤0.01% 3152
2025
Q2 		$414K Buy
106,863
+25,735
+32% +$139K ﹤0.01% 3245
2025
Q1 		$406K Sell
81,128
-165,958
-67% -$1.05M ﹤0.01% 3239
2024
Q4 		$1.78M Buy
247,086
+215,375
+679% +$1.65M ﹤0.01% 2658
2024
Q3 		$195K Buy
31,711
+968
+3% +$6.56K ﹤0.01% 3524
2024
Q2 		$204K Buy
30,743
+2,986
+11% +$22K ﹤0.01% 3617
2024
Q1 		$283K Sell
27,757
-718,424
-96% -$7.31M ﹤0.01% 3547
2023
Q4 		$8.39M Buy
746,181
+713,152
+2,159% +$2.98M ﹤0.01% 1930
2023
Q3 		$85.9K Buy
33,029
+4,956
+18% +$14.2K ﹤0.01% 3740
2023
Q2 		$99.1K Buy
+28,073
New +$126K ﹤0.01% 3728
2023
Q1 		– Sell
-425,849
Closed -$7.01M – 3868
2022
Q4 		$7.01M Buy
+425,849
New +$4.78M ﹤0.01% 2069
2022
Q2 		– Sell
-12,318
Closed -$75K – 4036
2022
Q1 		$75K Buy
12,318
+487
+4% +$3.59K ﹤0.01% 3890
2021
Q4 		$108K Sell
11,831
-1,109
-9% -$11.8K ﹤0.01% 3892
2021
Q3 		$147K Buy
12,940
+2,502
+24% +$30.4K ﹤0.01% 3870
2021
Q2 		$103K Sell
10,438
-402,385
-97% -$5.5M ﹤0.01% 3888
2021
Q1 		$5.83M Sell
412,823
-292,575
-41% -$4.73M ﹤0.01% 2295
2020
Q4 		$7.96M Buy
705,398
+269,439
+62% +$3.17M ﹤0.01% 1927
2020
Q3 		$5.75M Buy
435,959
+206,300
+90% +$4.12M ﹤0.01% 1943
2020
Q2 		$2.46M Buy
+229,659
New +$1.26M ﹤0.01% 2379
2017
Q1 		– Sell
-329
Closed -$320K – 3695
2016
Q4 		$320K Buy
+329
New +$295K ﹤0.01% 3435

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco's ALT Position: Q1 2026 in Review

Invesco increased its Altimmune (ALT) stake by 6.1% in Q1 2026, buying an estimated $55.3K and bringing the position to 227,857 shares worth $702K. The position accounts for ﹤0.01% of the portfolio, ranked #3013.

Invesco first reported a position in ALT in Q4 2016 and has held it in 22 quarters since. The position peaked at $8.39M in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Invesco held 227,857 shares of Altimmune worth $702K as of Q1 2026.
  • Invesco bought 13,033 Altimmune shares in Q1 2026, an estimated $55.3K.
  • Altimmune made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3013 holding.
  • Invesco first reported a position in Altimmune in Q4 2016 and has held it in 22 quarters since.
  • Invesco's Altimmune position peaked at $8.39M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.